系统性BCG免疫通过转录因子信号促进抗病毒Th1分化
该研究以小鼠呼吸道合胞病毒(RSV)感染模型探究BCG交叉保护机制,发现系统给予活BCG可改变染色质可及性、上调IRF1及STAT1/STAT2等转录因子,并经IL12/IL12R信号促进初始CD4+ T细胞向Th1分化,从而保护小鼠抵抗RSV感染。
要点
- 系统给予活BCG可保护小鼠抵抗RSV感染。
- BCG经IL12/IL12R信号促进初始CD4+ T细胞向Th1分化。
- BCG上调IRF1及STAT1/STAT2等干扰素信号相关转录因子。
核心结论
- 系统给予活BCG通过表观遗传重塑和IL-12信号协同驱动初始CD4+ T细胞向Th1分化,以抗原非依赖方式介导抗病毒交叉保护。
研究设计与样本
- 采用小鼠呼吸道合胞病毒(RSV)感染模型,系统给予活BCG进行免疫。
- 整合染色质可及性与转录组数据分析转录因子表达特征。
主要发现
- BCG-IV免疫保护小鼠抵抗RSV感染。
- BCG免疫引起单核细胞和中性粒细胞代谢重编程及固有免疫应答。
- BCG经IL12/IL12R介导初始CD4+ T细胞分化为Th1细胞群。
- BCG上调IRF1及STAT1、STAT2等干扰素信号与抗病毒应答相关转录因子。
临床怎么用
- 提示BCG的非特异性免疫训练可能作为抗病毒交叉保护的策略方向。
- 机制上关注IL-12信号与Th1分化在BCG介导保护中的作用。
局限性
- 机制证据主要来自小鼠RSV感染模型,外推至人群需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mycobacterium bovis bacillus Calmette-Guerin (BCG) is a form of live attenuated M. bovis-based vaccine used to prevent tuberculosis and other mycobacterial infections. BCG immunization also provides cross-protection against a broad range of viral pathogens. Recent studies show that a coordinated induction of innate and adaptive immune responses is involved, though the mechanisms are less defined. To investigate the cross-protection of BCG against virus infection, we used a mouse model of respiratory syncytial virus (RSV) infection and demonstrated that systemic administration of live BCG altered chromatin accessibility for transcriptional factor expression favoring Th1 response. Specifically, BCG-IV immunization protected mice against RSV infection. BCG immunization caused metabolic reprogramming in monocytes and neutrophils and innate immune response, leading to IL12/IL12R-mediated naïve CD4+ T cell differentiation to the Th1 cell population. Integrated analysis of chromatin openness and transcriptomic data revealed that BCG administration upregulated transcription factors including interferon regulatory factors (IRF1) and signal transducer and activator of transcription (STAT1 and STAT2), a signature for interferon signaling and antiviral response. This work highlights a crucial role for the adaptive immune response in mediating naïve CD4+ T cell differentiation and cross-protection through epigenetic remodeling for antiviral response against pathogens in an antigen-agnostic manner.
引用
- Wang R, Zhao Y, Yang J, et al. Systemic BCG administration induces transcription factor signature in CD4+ T cells that cooperates with IL-12 signaling to drive antiviral Th1 differentiation. Vaccine. 2026. PMID: 42142526. doi:10.1016/j.vaccine.2026.128720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。